Compare CNTA & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTA | LILAK |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United Kingdom | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 1.7B |
| IPO Year | 2021 | N/A |
| Metric | CNTA | LILAK |
|---|---|---|
| Price | $26.92 | $7.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $40.89 | $8.20 |
| AVG Volume (30 Days) | ★ 1.1M | 927.4K |
| Earning Date | 03-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.60 | $4.23 |
| 52 Week High | $30.58 | $9.13 |
| Indicator | CNTA | LILAK |
|---|---|---|
| Relative Strength Index (RSI) | 51.06 | 50.38 |
| Support Level | $24.62 | $7.53 |
| Resistance Level | $27.56 | $8.44 |
| Average True Range (ATR) | 1.37 | 0.30 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 43.26 | 62.00 |
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.